State Grid Corporation of China (China) — China
Pharmacology, Toxicology and Pharmaceutics · Life Sciences
16h-index646citations25works0.72yr avg
Accepting Students?
No reports yet. Know if this professor is taking students?
Research Topics
Plant-based Medicinal Research(5), Bioactive Natural Diterpenoids Research(4), Pharmacological Effects of Natural Compounds(4), Pain Mechanisms and Treatments(3), Inflammasome and immune disorders(3)
Publications25 total
International Immunopharmacology·2023· 8 cited
Acta Pharmaceutica Sinica B·2023· 22 citedOpen Access
Evidence-based Complementary and Alternative Medicine·2023· 3 citedOpen Access
Science Advances·2022· 44 citedOpen Access
Journal of Neuroinflammation·2021· 99 citedOpen Access
Journal of Asian Natural Products Research·2021· 13 cited
Pharmacology & Therapeutics·2021· 56 cited
International Immunopharmacology·2021· 23 cited
Therapeutic Advances in Medical Oncology·2021· 14 citedOpen Access
Chinese Chemical Letters·2020· 17 cited
Cancers·2020· 42 citedOpen Access
Biomedicine & Pharmacotherapy·2020· 21 citedOpen Access
Acta Pharmaceutica Sinica B·2020· 29 citedOpen Access
Journal of Neuroinflammation·2020· 38 citedOpen Access
page 1 of 2Next →
Frequent Co-authors
Tiantai Zhang(15), Chengjuan Chen(10), Gaona Shi(10), Yu Zhou(8), Jian‐Gong Shi(7), Chengbo Xu(6), Qing‐Lan Guo(6), Yazi Wei(6), Junmin Fu(5), Lei Wu(4), Lei Wu(4), Huan Xia(4), Min Hu(4), Yuzhuo Wu(4), Ningyu Fan(2), Hailun Jiang(2), Jianguo Xing(2), Rui Liu(2), Lan Sun(2), Lang Li(2)